Navigation Links
Unigene to Present at IBC's 4th Annual AsiaTIDES Oligonucleotide and Peptide® Conference
Date:2/27/2012

to provide the attendees of AsiaTIDES with a comprehensive review of recent advancements in the delivery of peptides, most notably Unigene's validated and most clinically advanced oral peptide delivery technology platform, as well as the company's late-stage and feasibility oral peptide programs developed via our Peptelligence™ platform," said Dr. Mehta. "Advances in the delivery of peptide therapeutics, particularly oral peptide technologies, have the opportunity to redefine the treatment regimen and market for numerous debilitating, chronic conditions.  Given this opportunity, the pharmaceutical industry is directing increasing attention and resources to companies and institutions that are developing next-generation peptide compounds, making a conference like AsiaTIDES an extremely valuable scientific and business development event."

About Unigene Laboratories, Inc.:

Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligence™ platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Investor Contact:
Unigene Laboratories, Inc.
Jenene Thomas
VP, Investor Relations and Business Administration
973-265-1107
jthomas@unigene.com

Media Contact:
Tiberend Strategic Advisors, Inc.
Jason Rando / Andrew Mielach
212-827-0020
jrando@tiberend.com
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit Continues to Grow in 2012
2. Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
3. Unigene Provides 2012 Business Outlook
4. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
5. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
6. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
7. Unigene Reports Third Quarter 2011 Financial Results
8. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
9. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
10. Nektar Presents Positive Proof-of-Concept Clinical Data for Its New Opioid Molecule, NKTR-181, at American Academy of Pain Medicines 28th Annual Meeting
11. Optimer Pharmaceuticals to Present at the 32nd Annual Cowen Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
(Date:5/23/2013)... 23, 2013   Direct to implant, or ... an appropriate option for many women with BRCA ... their breast cancer risk, or with breast cancer. ... and a second surgery to insert permanent implants, ... surgery as mastectomy can be a medically and ...
(Date:5/23/2013)... , May 23, 2013  Net Medical Xpress ... telemedicine market, announced today the company has signed a ... staffing company based in Huntsville, AL ... specializes in the staffing and recruitment of telemedicine physicians. ... of the final agreement, which is expected by June ...
Breaking Medicine Technology:First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3
... MINNEAPOLIS , May 3 Rescue Riders, a national ... to provide emergency medical assistance, has selected the HeartSine® samaritan® PAD ... , , ... more than 3,000 motorcycle-riding volunteers in 40 states who are trained ...
... , May 3 Par Pharmaceutical Companies, Inc. ... division, Par Pharmaceutical, has entered into an exclusive licensing agreement ... to market ezetimibe 10 mg tablets, the generic version ... is a cholesterol modifying agent with annual U.S. sales of ...
Cached Medicine Technology:Motorcyclist Volunteers Come to the Rescue With HeartSine AEDs 2Par Obtains Exclusive Rights to Market and Distribute Generic Zetia(R) in the U.S. 2Par Obtains Exclusive Rights to Market and Distribute Generic Zetia(R) in the U.S. 3
(Date:5/25/2013)... May 25, 2013 Pradaxa lawsuits ... life-threatening episodes of internal bleeding while using the blood thinner ... District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. ... Pradaxa side effect claims had been filed in ... from 705 claims reported by the Court on May 15th. ...
(Date:5/25/2013)... According to a new market report,"Global Homeland ... MarketsandMarkets is expected to reach $544.02 Billion by ... and studies the major market drivers, restraints, and ... of the World. , Browse:, , ... 87 Figures , 175 Pages and ...
(Date:5/25/2013)... Acuity Games ’ innovative brain games have ... Word Hunt is available today, expanding it beyond its ... 2, Sudoku and Matchematics will roll out over the next ... lifetime brain fitness measurement have been re-optimized for the iPhone's ... brain fitness measurement in your pocket. What could be ...
(Date:5/25/2013)... For college students, few events can ... are turning to prescription stimulants like Adderall to ... on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . , ... students who pick up Adderall, “just to help ... a physical and psychological dependency. While initially they ...
(Date:5/25/2013)... The current residents of Back2Basics - Long Term Drug and ... came together Saturday, May 18th to celebrate the company's 3rd ... residents got up to thank Roy Duprez, CEO and Founder ... recovery, and giving them a second chance at life. , ... realizing the need for a long-term facility. What started ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:Acuity Games Apps Come to the iPhone 2Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2
... Mother-Daughter Co-authors Share How Eating Disorders Affect Loved Ones At ... The Remuda Cornerstone Bookstore on May ... Disorders,( http://www.remudaranch.com ), the nation,s leading and largest inpatient,treatment center ... book signing event with the authors of the new book ...
... even within normal range associated with dangers , , TUESDAY, ... within the normal range may increase the risk of ... finds. , Thyrotropin, a hormone produced by the pituitary ... the thyroid gland to stimulate its growth and function. ...
... in German . , Leipzig. Unlike in ... Republic and Poland did not so far lead to massive ... there are other reasons for the presence of empty apartments, ... findings of a research project conducted by the Helmholtz Centre ...
... overall winner to launch Partner Enablement ... prepares for significant partner growth, ENGLEWOOD CLIFFS, N.J., ... recovery service provider and recent Gold,5-Star overall winner in ... Enablement Program at Interop 2008 in Las Vegas, NV,in ...
... 3,000,long-term care professionals are meeting in Columbus May ... personnel from skilled nursing facilities,assisted living residences, and ... The Ohio Health Care Association (OHCA), which represents ... state, is hosting its 62nd Annual,Convention & Exhibition ...
... Downs syndrome children who wear bifocal lenses to help them ... years, according to new research from Cardiff University. , The ... Unit has studied the reasons for poor focussing among children ... children in the study who adopted bifocals to ease difficulties ...
Cached Medicine News:Health News:Authors Of New Critically Acclaimed Book 'Distorted' Share Their Journey From an Eating Disorder at a Book Signing Event in Wickenburg 2Health News:Pituitary Hormone May Boost Women's Heart Risk 2Health News:Shrinkage and aging are Europe-wide challenges 2Health News:Shrinkage and aging are Europe-wide challenges 3Health News:Shrinkage and aging are Europe-wide challenges 4Health News:Intronis Technologies to Launch Partner Enablement Program at INTEROP 2008 2Health News:Ohio Health Care Association Hosts Midwest's Largest Long-Term Care Convention in Columbus 2Health News:A life 'lens' ordinary 2
Sub Pectoral Bra...
Bandeau Bra...
Post-Surgical compression garments...
... Cobalt Binding (ACB®) Test is a clinical ... (IMA®) by measuring the cobalt binding capacity ... First identified in the early 1990s, IMA ... contact with ischemic tissue in the heart. ...
Medicine Products: